We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current ELDN market cap is 60.01M. The company's latest EPS is USD -1.6665 and P/E is -1.45.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -10.6M | -58.69M | -11.11M | -10.35M | -11.2M |
| Net Income | -10.47M | -58.38M | -10.77M | -9.58M | -10.35M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -16.05M | -18.47M | -36.87M | -88.43M | -43M |
| Net Income | -16.01M | -22.81M | -34.51M | -87.97M | -40.33M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 149.59M | 92.79M | 82.31M | 106.79M | 96.07M |
| Total Liabilities | 8.49M | 8.61M | 7.51M | 6.84M | 4.73M |
| Total Equity | 141.09M | 84.18M | 74.79M | 99.95M | 91.34M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 10.93M | 197.19M | 170.55M | 92.79M | 89.07M |
| Total Liabilities | 1.47M | 6.59M | 6.55M | 8.61M | 5.65M |
| Total Equity | 9.47M | 190.6M | 164M | 84.18M | 83.42M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -18.94M | -28.42M | -9.92M | -18.15M | -30.4M |
| Investing | N/A | N/A | N/A | -30.33M | -55.36M |
| Financing | N/A | N/A | N/A | 33.02M | 33.02M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -13.86M | -15.21M | -28.91M | -28.42M | -39.53M |
| Investing | N/A | 11.04M | N/A | N/A | -45.29M |
| Financing | 9.68M | 109.58M | -449k | N/A | 33.02M |
| Market Cap | 60.01M |
| Price to Earnings Ratio | -1.45 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 12.64 |
| Price to Book Ratio | 0.7 |
| Dividend Yield | - |
| Shares Outstanding | 24.2M |
| Average Volume (1 week) | 151.74k |
| Average Volume (1 Month) | 134.06k |
| 52 Week Change | 6.90% |
| 52 Week High | 2.95 |
| 52 Week Low | 1.07 |
| Spread (Intraday) | 0.12 (4.72%) |
| Company Name | Eledon Pharmaceuticals Inc |
| Address |
8 the green dover, delaware 19901 |
| Website | https://www.eledon.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
